Download PDF

Other users also viewed these articles

The importance of disease coding following the diagnosis of chronic kidney disease: From ICD-10 code N18.9 to the role of clinical laboratories María Isabel Troya; Jordi Bover; Anna Cia Hidalgo; Susana Malumbres; Maya Sánchez-Bayá; Elisabet Massó; Verónica Coll-Brito; Paula Anton-Pampols; Iara da Silva; Jordi Soler-Majoral; Elisabeth Marcos; Beatriz Moreiras Abril; Noemí Pérez-León; Marta Morera García; Joan Pau Golf Zaragoza; Xavier Jusmet Miguel; Yolanda Lejardi Estevez; Rosa López-Alarcón; Ignacio Blanco; Cristian Morales Indiano; Silvia Gràcia-Garcia; Antonio Buño Soto; José Luis Górriz; Juan Manuel Buades; Alberto Ortiz; Emilio Sánchez; Jordi Ara;
10.1016/j.nefroe.2025.501410
In response to optimizing osteoporosis management in CKD patients Jordi Bover; Carlos Gómez-Alonso; Enrique Casado; Juan Francisco Navarro-González;
Nefrologia (English Version). 2025;45:346-8
Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain Roberto Alcázar-Arroyo; María G Crespo-Leiro; Jordi Bover; Juan Oliva; Miren Sequera-Mutiozabal; Simona Gradari; Anisia Martínez-López; Blanca López-Chicheri; Neus Vidal-Vilar; Susana Aceituno; Marta Cobo;
Nefrologia (English Version). 2024;44:709-20